In the same study other miRNAs were also found as promising candidate biomarkers for relapsing-remitting MS and progressive MS, including the platelet-related miRNAs miR-30b-5p, miR-223, and miR-15-5p, the last predicted as regulator of the fibroblast growth factor-2 gene (FGF2), a gene involved in demyelination and remyelination (Fenoglio et al., 2012). The gene discussed is FGF2; the disease is relapsing-remitting multiple sclerosis.